Search
for

    Sort by

    Research 151–180 of 1000+

    1. ORAL AND TOPICAL FINASTERIDE IN THE TREATMENT OF MALE ANDROGENETIC ALOPECIA – NARRATIVE REVIEW Archiv Euromedica · 2026
    2. Thyroid Hormones Directly Alter Human Hair Follicle Functions: Anagen Prolongation and Stimulation of Both Hair Matrix Keratinocyte Proliferation and Hair Pigmentation The Journal of Clinical Endocrinology & Metabolism · 2008 · 115 citations
    3. Hair Follicle Immune Privilege Revisited: The Key to Alopecia Areata Management 2017 · 102 citations
    4. The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders ˜The œAmerican journal of medicine · 1995 · 57 citations
    5. Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist Journal of nanobiotechnology · 2023 · 6 citations
    6. No. 350-Hirsutism: Evaluation and Treatment 2017 · 5 citations
    7. Persistent escalation of alcohol consumption by mice exposed to brief episodes of social defeat stress: suppression by CRF-R1 antagonism 2018 · 38 citations
    8. The Double-Edged Proteins in Cancer Proteomes and the Generation of Induced Tumor-Suppressing Cells (iTSCs) Proteomes · 2023 · 4 citations
    9. Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome Cancer Treatment Reviews · 2023 · 7 citations
    10. The evaluation and management of hirsutism*1 2003 · 195 citations
    11. 9 Diagnosis and therapy of hyperandrogenism Baillière's clinical obstetrics and gynaecology · 1997 · 23 citations
    12. Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters Frontiers in Endocrinology · 2023
    13. Symmetrical alopecia in the dog In Practice · 1999 · 7 citations
    14. Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome F&S Reports · 2023 · 2 citations
    15. Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism European Journal of Clinical Investigation · 2011 · 39 citations
    16. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH International Journal of Oncology · 2016 · 21 citations
    17. Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model Journal of Assisted Reproduction and Genetics · 2026
    18. A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome Fertility and sterility · 2008 · 24 citations
    19. Hidradenitis Suppurativa and Wound Management 2015 · 17 citations
    20. CLINICAL UPDATES IN HAIR Dermatologic Clinics · 1997 · 19 citations
    21. Moxibustion improves ovarian function based on the regulation of the androgen balance Experimental and Therapeutic Medicine · 2021 · 2 citations
    22. Clomiphene Citrate as Nanomedicine Assistance in Ovulatory Disorders and Its Hyphenated Techniques 2023
    23. Female pattern hair loss Indian Journal of Dermatology, Venereology and Leprology · 2013 · 23 citations
    24. Budesonide for maintenance of remission in Crohn's disease Cochrane library · 2014 · 156 citations
    25. Cardiovascular effects of hormone therapy for prostate cancer Drug Healthcare and Patient Safety · 2015 · 18 citations
    26. Update on Melasma—Part I: Pathogenesis Dermatology and Therapy · 2022 · 10 citations
    27. Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation Facial Plastic Surgery Clinics of North America · 2019 · 5 citations
    28. Plasma β‐Endorphin Concentrations During Natural and Artificially Induced Winter Hair Growth in Mink (<i>Mustela vison</i>) Annals of the New York Academy of Sciences · 1999 · 2 citations
    29. SASH1 Mutations and Hereditary Disorders of Pigmentation: Review of Literature Pigment Cell & Melanoma Research · 2025 · 1 citations
    30. Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells Frontiers in Pharmacology · 2025